Cargando…

Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines

Detalles Bibliográficos
Autores principales:	Angelis, Aris, Darrow, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983546/ https://www.ncbi.nlm.nih.gov/pubmed/33785254 http://dx.doi.org/10.1016/j.vaccine.2021.03.053

Ejemplares similares

Using motivational interviewing techniques to inform decision-making for COVID-19 vaccination
por: Zolezzi, Monica, et al.
Publicado: (2021)

Safeguarding vaccine production and supply strategies for polio eradication endgame
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2021)

Shared decision-making in the context of COVID-19
por: Westphal, Glauco Adrieno, et al.
Publicado: (2020)

Making evidence-based selections of influenza vaccines
por: Childress, Billy-Clyde, et al.
Publicado: (2014)

Pregnancy, breastfeeding and the SARS-CoV-2 vaccine: an ethics-based framework for shared decision-making
por: Zipursky, Jonathan S., et al.
Publicado: (2021)

Supporting individual vaccine decision-making: A role for vaccination counselors
por: Ulrich, Angela K., et al.
Publicado: (2022)

Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END)
por: McCaul, Michael, et al.
Publicado: (2022)

The Use of External Controls in FDA Regulatory Decision Making
por: Jahanshahi, Mahta, et al.
Publicado: (2021)

From shared decision making to patient-centered decision making
por: Fineberg, Harvey V
Publicado: (2012)

A mitochondrial strategy for safeguarding the reprogrammed genome
por: Prigione, Alessandro, et al.
Publicado: (2014)

US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine
por: Dal-Ré, Rafael
Publicado: (2021)

How does the West African Health Organisation (WAHO) contribute to the evidence based decision-making and practice during COVID-19 pandemic in ECOWAS region?
por: Sombié, Issiaka, et al.
Publicado: (2020)

Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
por: Sun, Wellington
Publicado: (2023)

The FDA Changed Everything
por: Geantă, Marius, et al.
Publicado: (2017)

Leveraging GIS and spatial analysis for informed decision-making in COVID-19 pandemic
por: Ahasan, Rakibul, et al.
Publicado: (2021)

Looking Beyond Cognition for Risky Decision Making: COVID-19, the Environment, and Behavior
por: Broomell, Stephen B., et al.
Publicado: (2021)

Symptoms of a broken system: the gender gaps in COVID-19 decision-making
por: van Daalen, Kim Robin, et al.
Publicado: (2020)

Enhancing COVID-19 decision making by creating an assurance case for epidemiological models
por: Habli, Ibrahim, et al.
Publicado: (2020)

Making COVID-19 vaccinations accessible for people with disabilities
por: Rotenberg, Sara, et al.
Publicado: (2021)

Setting decision‐making criteria: is medical education ready for shared decision making?
por: Schut, Suzanne, et al.
Publicado: (2019)

COVID-19 vaccine decisions: considering the choices and opportunities
por: Hotez, Peter J., et al.
Publicado: (2021)

Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
por: Kanavos, Panos, et al.
Publicado: (2015)

The Impact of Science-Unbased Measures Against COVID-19 in Clinical Decision-Making Process
por: Pimentel, João Vitor Cândido, et al.
Publicado: (2020)

Governance of the Covid-19 response: a call for more inclusive and transparent decision-making
por: Rajan, Dheepa, et al.
Publicado: (2020)

COVID-19 cancer conundrum—evidence driving decisions or the lack of it?
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2020)

We’re not making evidence-based decisions: Introducing a tool to assess strengths and weaknesses in healthcare providers
por: Spurr, Kathleen F, et al.
Publicado: (2016)

Shifting Power in Practice: The Importance of Contextual and Experiential Evidence in Guiding MCH Decision Making
por: Powis, Laura, et al.
Publicado: (2022)

Improving institutional platforms for evidence-informed decision-making: getting beyond technical solutions
por: Mecaskey, Jeffrey, et al.
Publicado: (2023)

WAAR (World Alliance against Antibiotic Resistance): Safeguarding antibiotics
por: Carlet, Jean, et al.
Publicado: (2012)

Space technology: A powerful tool for safeguarding world heritage
por: Luo, Lei, et al.
Publicado: (2023)

Safeguarding community-centred global health research during crises
por: Agampodi, Thilini, et al.
Publicado: (2023)

On salesperson judgment and decision making
por: Lam, Son K., et al.
Publicado: (2021)

Decision-making for PCV in adults
por: McLaughlin, John M., et al.
Publicado: (2018)

Off the back burner: diverse and gender-inclusive decision-making for COVID-19 response and recovery
por: Bali, Sulzhan, et al.
Publicado: (2020)

Public Health Decision-Making in the Real World: Four Points to Reshape It After COVID-19
por: Torri, Emanuele, et al.
Publicado: (2020)

’Make exercise the elixir across an economic divide’: A message to COVID-19 decision makers
por: Patricios, J, et al.
Publicado: (2020)

Vaccine Impact Data Should Support Country Decision Making
por: Nelson, E Anthony S, et al.
Publicado: (2017)

Well-Being Data Gathering during COVID-19: Exploring the Feasibility of a Contact Tracing and Community Well-Being Safeguarding Framework
por: Musikanski, Laura, et al.
Publicado: (2021)

Changing FDA Approval Standards: Ethical Implications for Patient Consent
por: Darrow, Jonathan J., et al.
Publicado: (2021)

Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_tv6mcloa39iiiveh0puk5573ao